Incident Impaired Cognitive Function in Sarcopenic Obesity: Data From the National Health and Aging Trends Survey.
Incident Impaired Cognitive Function in Sarcopenic Obesity: Data From the National Health and Aging Trends Survey.
复制标题
DOI:
10.1016/j.jamda.2020.09.008
复制
发表时间:
2021-04
影响因子:
7.6
通讯作者:
Mackenzie TA
中科院分区:
文献类型:
--
作者:
Batsis JA;Haudenschild C;Roth RM;Gooding TL;Roderka MN;Masterson T;Brand J;Lohman MC;Mackenzie TA
The prevalence of obesity with sarcopenia is increasing in adults aged ≥65 years. This geriatric syndrome places individuals at risk for synergistic complications that leads to long-term functional decline. We ascertained the relationship between sarcopenic obesity and incident long-term impaired global cognitive function in a representative US population. A longitudinal, secondary data set analysis using the National Health and Aging Trends Survey. Community-based older adults in the United States. Participants without baseline impaired cognitive function aged ≥65 years with grip strength and body mass index measures. Sarcopenia was defined using the Foundation for the National Institutes of Health Sarcopenia Project grip strength cut points (men <35.5 kg; women <20 kg), and obesity was defined using standard body mass index (BMI) categories. Impaired global cognition was identified as impairment in the Alzheimer’s Disease-8 score or immediate/delayed recall, orientation, clock-draw test, date/person recall. Proportional hazard models ascertained the risk of impaired cognitive function over 8 years (referent = neither obesity or sarcopenia). Of the 5822 participants (55.7% women), median age category was 75 to 80, and mean grip strength and BMI were 26.4 kg and 27.5 kg/m2, respectively. Baseline prevalence of sarcopenic obesity was 12.9%, with an observed subset of 21.2% participants having impaired cognitive function at follow-up. Compared with those without sarcopenia or obesity, the risk of impaired cognitive function was no different in obesity alone [hazard ratio (HR) 0.98; 95% confidence interval (CI) 0.82–1.16]), but was significantly higher in sarcopenia (HR 1.60; 95% CI 1.42–1.80) and sarcopenic obesity (HR 1.20; 95% CI 1.03–1.40). There was no significant interaction term between sarcopenia and obesity. Both sarcopenia and sarcopenic obesity are associated with an increased long-term risk of impaired cognitive function in older adults.
登录
查看更多内容
影响因子:
37.8
作者:
Jensen MD;Ryan DH;Apovian CM;Ard JD;Comuzzie AG;Donato KA;Hu FB;Hubbard VS;Jakicic JM;Kushner RF;Loria CM;Millen BE;Nonas CA;Pi-Sunyer FX;Stevens J;Stevens VJ;Wadden TA;Wolfe BM;Yanovski SZ;Jordan HS;Kendall KA;Lux LJ;Mentor-Marcel R;Morgan LC;Trisolini MG;Wnek J;Anderson JL;Halperin JL;Albert NM;Bozkurt B;Brindis RG;Curtis LH;DeMets D;Hochman JS;Kovacs RJ;Ohman EM;Pressler SJ;Sellke FW;Shen WK;Smith SC Jr;Tomaselli GF;American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Obesity Society
通讯作者:
Obesity Society
影响因子:
3.3
作者:
Kera, Takeshi;Kawai, Hisashi;Obuchi, Shuichi
通讯作者:
Obuchi, Shuichi
影响因子:
5.8
作者:
Deckers, Kay;van Boxtel, M. P. J.;Kohler, S.
通讯作者:
Kohler, S.
影响因子:
5
作者:
Haapanen, N;Miilunpalo, S;Vuori, I
通讯作者:
Vuori, I
影响因子:
9.9
作者:
Galvin, James E.;Roe, Catherine M.;Morris, John C.
通讯作者:
Morris, John C.